Stay up to date with ever-changing regulatory requirements.
Meet the IQVIA Regulatory Intelligence team at this year’s RAPS Convergence on booth #530. We will be showcasing our industry leading regulatory solution, which will give you access to regulatory information for human drugs and biologics, medical devices and IVDs in over 110 countries, regions, and international organizations. Here you will get the latest regulatory insights and real-time updates you need all in one place.
The RAPS Convergence is the largest and most recognized annual gathering of global regulatory affairs professionals and brings together representatives of industry, regulatory bodies, research, academia, and clinical organizations directly involved in managing the regulatory process and aligning science, regulation, and business strategy.
IQVIA Presents at RAPS
Empowering global regulatory affairs professional with automated surveillance solutions.
Speakers:
Michael King, Senior Director, Product Strategy, IQVIA
Bridget Wiseman, Director, Offering Management, Regulatory Intelligence, IQVIA
The range of global regulations and standards requiring monitoring can vary from company to company depending upon their target therapeutic area and product composition and, with the advent of software and AI embedded solutions, require regulatory affairs professionals to actively monitor an ever-increasing volume of content around the design, manufacture, sale, import, distribution, and post market activities. Failure to identify updated regulations and to meet the new requirements can result in fines and penalties, stop shipments and importation issues, and damage relationships with regulators and customers.
Supporting professionals with automated solutions for the tracking of global regulations and the creation of impact assessment plans can yield significant benefits by optimizing the ability to address regulatory change in real time and provide a single source of truth when tracking a company’s progress in meeting updated/ new regulation(s). Further enhancing end-to-end regulatory surveillance with Generative AI can increase the quality of remediation plans and timeliness of a company’s compliance to regulatory change.
Learning Objectives:
For more information on IQVIA Regulatory Intelligence, please visit this page.
Stay up to date with ever-changing regulatory requirements.